
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $34.1M | -- | -- | $0.26 | -- |
08/01/2025 | Q2 | $31.1M | -- | -- | $0.14 | -- |
05/01/2025 | Q1 | $34.2M | $34.9M | -$0.09 | $0.18 | -$0.27 |
03/06/2025 | Q4 | $30.8M | $30.8M | -$0.12 | $0.18 | -$0.30 |
10/31/2024 | Q3 | $31.3M | $29.3M | -$0.15 | $0.19 | -$0.34 |
08/01/2024 | Q2 | $28.6M | $28M | -$0.17 | $0.13 | -$0.30 |
05/02/2024 | Q1 | $31M | $31.7M | -$0.01 | $0.20 | -$0.21 |
02/26/2024 | Q4 | $26.3M | $26.3M | -$0.15 | $0.05 | -$0.20 |
11/13/2023 | Q3 | $26.4M | $29.3M | -$0.10 | $0.06 | -$0.16 |
08/07/2023 | Q2 | $25.5M | $30.4M | -$0.18 | $0.01 | -$0.19 |
05/08/2023 | Q1 | -- | $33.1M | $0.02 | -- | -- |
02/27/2023 | Q4 | -- | $29.3M | -$0.05 | -- | -- |
11/07/2022 | Q3 | -- | $21.9M | -$0.22 | -- | -- |
08/08/2022 | Q2 | -- | $20.3M | -$0.29 | -- | -- |
05/09/2022 | Q1 | -- | $24.3M | -$0.15 | -- | -- |
03/14/2022 | Q4 | -- | $21.1M | -$0.23 | -- | -- |
11/08/2021 | Q3 | -- | $18M | $0.28 | -- | -- |
08/09/2021 | Q2 | -- | $17.2M | $0.20 | -- | -- |
05/10/2021 | Q1 | -- | $19.8M | -$0.08 | -- | -- |
03/11/2021 | Q4 | -- | $16.4M | -$0.37 | -- | -- |
11/09/2020 | Q3 | -- | $16M | -$0.30 | -- | -- |
08/10/2020 | Q2 | -- | $14.1M | -$0.25 | -- | -- |
05/07/2020 | Q1 | -- | $18.9M | -$0.11 | -- | -- |
03/12/2020 | Q4 | -- | $17.6M | $2.65 | -- | -- |
11/11/2019 | Q3 | -- | $17.9M | -$0.22 | -- | -- |
08/08/2019 | Q2 | -- | $17.3M | -$0.32 | -- | -- |
05/09/2019 | Q1 | -- | $20.4M | -$0.19 | -- | -- |
03/14/2019 | Q4 | -- | -$903K | $0.14 | -- | -- |
11/09/2018 | Q3 | -- | $23.5M | -$0.24 | -- | -- |
08/08/2018 | Q2 | -- | $21.8M | -$0.29 | -- | -- |
05/09/2018 | Q1 | -- | $19.3M | -$0.15 | -- | -- |
03/15/2018 | Q4 | -- | $15.3M | -$0.13 | -- | -- |
11/13/2017 | Q3 | -- | $15.5M | -$0.10 | -- | -- |
08/14/2017 | Q2 | -- | $12.9M | -$0.18 | -- | -- |
05/11/2017 | Q1 | -- | $10.7M | -$0.12 | -- | -- |
03/20/2017 | Q4 | -- | $9.7M | $0.02 | -- | -- |
11/14/2016 | Q3 | -- | $9.4M | $0.05 | -- | -- |
08/15/2016 | Q2 | -- | $9.7M | $0.02 | -- | -- |
05/12/2016 | Q1 | -- | $6.7M | -$0.25 | -- | -- |
03/30/2016 | Q4 | -- | $6.8M | -$0.12 | -- | -- |
11/16/2015 | Q3 | -- | $6.7M | -$0.09 | -- | -- |
Asure Software reported $34.9M worth of top line sales in its most recent quarter.
Asure Software announced earnings per share of -$0.09 which represents a miss of analyst forecast a $0.18 per share.
Asure Software reported $24.6M that represents $0.91 per share over the last quarter.
Asure Software's earnings are forecast to grow from -$0.45 per share to $0.62 per share next year representing an increase of --.
Asure Software's next earnings date is August 1, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.